How would you rate this video
Thank you !
Thank you for your feedback! your rating has been recorded.
Lipitension - Interplay between Hypertension and Dyslipidaemia
Calcium antagonists have become the gold standard of antihypertensive efficacy. Among various dihydropyridine calcium antagonists, amlodipine is most often considered. This is due to its being more powerful in lowering BP than other dihydropyridine calcium antagonists, and also more due to its extensive use by practicing physicians all over the world. CCBs are widely used for the treatment of hypertension and have effectiveness BP, major CV events, and mortality outcomes. Most RCTs demonstrating the benefits of CCBs on outcomes have used dihydropyridines (especially amlodipine).
Related Videos
Related Videos
Fungal infection and its...
Swedeheart Registry Video
Oasis-5 Trial
Role of Fondaparinux in...
Dr.Shamir Mehta on Oasis...
OASIS 8- Futura Trial...
SWEDEHEART Registry by Dr...
Dr. Dhiman Kahali on...
Dapagliflozin - A Must...
Drishti Conclave 5 -...
Related Webinars
-
button
-
DyslipidemiaCardiomypathy
There are 2 speakers in this webinar
DyslipidemiaCardiomypathyRole of Icosapent Ethyl in Reducing the Risk of Cardiovascular Events
DyslipidemiaCardiomypathy -
CardiacDiabetology
There are 2 speakers in this webinar
CardiacDiabetologyFamilial Hypercholesterolemia Conclave
CardiacDiabetology -
Heart FailureHypertension
There are 2 speakers in this webinar
Heart FailureHypertensionDiastology Global Insights on Heart Failure Management
Heart FailureHypertension -
CardiomypathyHeart Failure
There are 2 speakers in this webinar
CardiomypathyHeart FailureDiastology Global Insights on Heart Failure Management
CardiomypathyHeart Failure
Webinar Speakers
Related Webinars
No result found. Choose another option for better results.